Previous studies assessed the survival of spiral ganglion cells after a period up to six weeks following deafness before treatment with BDNF plus fibroblast growth factor 1 (FGF1) [19] or before combined treatment with GDNF and ES [17] or BDNF and ES [20]. This evidence concerns the gene FGF1 and deafness.